[The efficacy and safety of human glucagon-like peptide-1 analogue liraglutide in newly diagnosed type 2 diabetes with glycosylated hemoglobin A1c > 9].

医学 利拉鲁肽 内科学 糖尿病 二甲双胍 内分泌学 2型糖尿病 瑞格列奈 胰岛素 2型糖尿病 艾塞那肽 胰高血糖素样肽-1 糖化血红素 低血糖 血红蛋白 胰高血糖素 血糖性 胃肠病学 肠促胰岛素 甘精胰岛素 1型糖尿病
作者
Lihui Yan,Shaozhen Wang,Pin Chen,Chen Chen,Zhulin Shao,Xiangjin Xu,Qin Huang
出处
期刊:Chinese Journal of Internal Medicine [Chinese Medical Association]
卷期号:54 (4): 307-12 被引量:1
标识
DOI:10.3760/cma.j.issn.0578-1426.2015.04.007
摘要

To evaluate the efficacy and safety of human glucagon-like peptide-1 analogue liraglutide in newly diagnosed type 2 diabetes mellitus (T2DM) with glycosylated hemoglobin A1c (HbA1c) > 9%.This was an open-labelled, randomized, parallel-group, treat-to-target trial. Newly diagnosed T2DM patients with HbA1c > 9% were enrolled. These patients were treated with metformin with repaglinide and randomized to receive once-daily liraglutide (LIRA, n=25) or the insulin glargine (IGla, n=24) at bedtime. Efficacy and safety were assessed and compared after 18-month treatment.(1) Compared with the baseline, patients with LIRA had significantly reduced mean body weight,BMI and waist circumference (P < 0.01), whereas, the above indexes were increased (P < 0.01) in patients treated with IGla. (2) After 18 months of treatment, fasting plasma glucose (FPG), 2-hour plasma glucose after a 75g oral glucose load (2hPG) and HbA1c were significantly improved in all patients (P < 0.01), with 2hPG, mean blood glucose (MBG), the largest amplitude of glycemic excursions (LAGE), mean amplitude of glycemic excursions (MAGE) were significantly lower in LIRA group than in IGla group (all P < 0.05). (3) HOMA-IR decreased in both groups (P < 0.05). However, ΔI30/ΔG30, AUCCP180 and Matsuda index were only significantly increased in patients treated with LIRA (respectively, 4.88 ± 1.55 vs 7.60±1.91, 9.23 ± 2.66 vs 13.18 ± 2.72, 39.28 ± 20.35 vs 54.64 ± 23.34, all P < 0.01), while HOMA-IR reduced (4.41 ± 1.58 vs 3.52 ± 1.44, P < 0.05). But in IGla group only HOMA-IR was reduced (4.92 ± 1.84 vs 4.57 ± 1.80, P < 0.05). The index of ΔI30/ΔG30, AUCCP180 and Matsuda index in LIRA group are higher than those of indexes in IGla group(respectively, 7.60 ± 1.91 vs 4.18 ± 1.00, 13.18 ± 2.72 vs 10.53 ± 2.68,54.64 ± 23.34 vs 41.65 ± 17.84, all P < 0.05), while HOMA-IR is lower (3.52 ± 1.44 vs 4.57 ± 1.80, P< 0.05). (4) The rate of HbA1c ≤ 6.5% and the dosages of oral anti-diabetic drugs in LIRA group were significantly better than that in IGla group. (5) No significant differences were observed in hypoglycemic episodes and adverse events between two groups.It seems that liraglutide is superior to insulin glargine in newly diagnosed T2DM patients with HbA1c > 9% in improving beta-cell function, insulin sensitivity and glucose homeostasis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Frenger发布了新的文献求助10
刚刚
隐形曼青的应助被BlogY采纳,获得10
刚刚
刚刚
刚刚
1秒前
1秒前
It发布了新的文献求助20
1秒前
NexusExplorer的应助被琴power采纳,获得10
1秒前
1秒前
LIzx完成签到,获得积分10
2秒前
2秒前
2秒前
香蕉觅云的应助被lrg采纳,获得10
2秒前
3秒前
风吹麦浪的应助被Camellia采纳,获得10
3秒前
4秒前
4秒前
4秒前
动人的乾发布了新的文献求助10
4秒前
5秒前
张俊伟完成签到,获得积分10
5秒前
秋风的应助被王为云采纳,获得10
5秒前
5秒前
李李发布了新的文献求助10
5秒前
5秒前
魔幻苑睐关注了科研通微信公众号
5秒前
5秒前
UU完成签到,获得积分10
6秒前
搜集达人的应助被科研通管家采纳,获得10
6秒前
DW的应助被yalin采纳,获得10
6秒前
xucc的应助被科研通管家采纳,获得10
6秒前
NexusExplorer的应助被科研通管家采纳,获得10
6秒前
6秒前
蓝天的应助被科研通管家采纳,获得10
6秒前
6秒前
6秒前
6秒前
彭于晏的应助被科研通管家采纳,获得10
6秒前
我是老大的应助被呜哪啦采纳,获得10
6秒前
新小增完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170166
求助须知:如何正确求助?哪些是违规求助? 9563213
关于积分的说明 21768986
捐赠科研通 7761665
什么是DOI,文献DOI怎么找? 3430630
关于科研通互助平台的介绍 2554458
邀请新用户注册赠送积分活动 2475393